Concise review: In search of unlimited sources of functional human pancreatic beta cells

Stem Cells Translational Medicine

Volumn 2, Issue 1, 2013, Pages 61-67

  Scharfmann, Raphael ^a   Rachdi, Latif ^a   Ravassard, Philippe ^b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Beta cells; Diabetes; Differentiation; Pancreas

Indexed keywords

INSULIN; ION CHANNEL; TRANSCRIPTION FACTOR MAFB;

ACINAR CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL THERAPY; EMBRYONIC STEM CELL; ENDOCRINE CELL; GENE EXPRESSION; GENE TRANSFER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; RODENT; ANIMAL; CELL CULTURE; DIABETES MELLITUS; METABOLISM; PANCREAS; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DIABETES MELLITUS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INSULIN; INSULIN-SECRETING CELLS; PANCREAS; REGENERATIVE MEDICINE;

MLCS; MLOWN;

EID: 84873462829     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0120     Document Type: Review

References (81)

1. Ravassard P, Hazhouz Y, Pechberty S et al. A genetically engineered human pancreatic beta cell line exhibiting glucose-inducible insulin secretion. J Clin Invest 2011;121:3589-3597.
2. McCluskey JT, Hamid M, Guo-Parke H et al. Development and functional characterization of insulin-releasing human pancreatic beta cell lines produced by electrofusion. J Biol Chem 2011;286:21982-21992.
3. Van Lommel L, Janssens K, Quintens R et al. Probe-independent and direct quantification of insulin mRNA and growth hormone mRNA in enriched cell preparations. Diabetes 2006;55:3214-3220.
4. Rahier J, Guiot Y, Goebbels RM et al. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008;10(suppl 4):32-42.
5. Ferrannini E. The stunned beta cell: A brief history. Cell Metab 2010;11:349-352.
6. Melloul D, Marshak S, Cerasi E. Regulation of insulin gene transcription. Diabetologia 2002;45:309-326.
7. Brissova M, Fowler MJ, Nicholson WE et al. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem 2005; 53:1087-1097.
8. Cabrera O, Berman DM, Kenyon NS et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci USA 2006;103:2334-2339.
9. Dorrell C, Schug J, Lin CF et al. Transcriptomes of the major human pancreatic cell types. Diabetologia 2011;54:2832-2844.
10. Braun M, Ramracheya R, Bengtsson M et al. Voltage-gated ion channels in human pancreatic beta-cells: Electrophysiological characterization and role in insulin secretion. Diabetes 2008;57:1618-1628.
11. Henquin JC, Dufrane D, Nenquin M. Nutrient control of insulin secretion in isolated normal human islets. Diabetes 2006;55:3470-3477.
12. Eizirik D, Pipeleers D, Ling Z et al. Major species differences between humans and rodents in the susceptibility to pancreatic -cell injury. Proc Natl Acad Sci USA 1994;91:9253-9256.
13. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967;16:35-39.
14. Van De Winkel M, Pipeleers D. Autofluorescence-activated cell sorting of pancreatic islet cells: Purification of insulin-containing B-cells according to glucose-induced changes in cellular redox state. Biochem Biophys Res Commun 1983;114:835-842.
15. Gazdar A, Chick W, Oie H et al. Continuous, clonal, insulinand somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proc Natl Acad Sci USA 1980;77:3519-3523.
16. Chick WL, Warren S, Chute RN et al. A transplantable insulinoma in the rat. Proc Natl Acad Sci USA 1977;74:628-632.
17. Good ME, Nelson TK, Simon AM et al. A functional channel is necessary for growth suppression by Cx37. J Cell Sci 2011;124:2448-2456.
18. Asfari M, Janjic D, Meda P et al. Establishment of 2-mercaptoethanol-dependent differentiated insulin secreting cell lines. Endocrinology 1992;130:167-178.
19. Eizirik DL, Sammeth M, Bouckenooghe T et al. The human pancreatic islet transcriptome: Expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet 2012;8:e1002552.
20. Santerre R, Cook R, Criscl R et al. Insulin synthesis in a clonal cell line of simian virus 40transformed hamster pancreatic beta cells. Proc Natl Acad Sci USA 1981;78:4339-4342.
21. Olson LK, Redmon JB, Towle HC et al. Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. J Clin Invest 1993;92: 514-519.
22. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985;315:115-122.
23. Efrat S, Linde S, Kofod H et al. cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci USA 1988;85:9037-9041.
24. Efrat S, Leiser M, Surana M et al. Murine insulinoma cell line with normal glucose-regulated insulin secretion. Diabetes 1993;42:901-907.
25. Knaack D, Fiore DM, Surana M et al. Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes 1994;43:1413-1417.
26. Kalousova A, Mavropoulos A, Adams BA et al. Dachshund homologues play a conserved role in islet cell development. Dev Biol 2010; 348:143-152.
27. Miyazaki J, Araki K, Yamato E et al. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: Special reference to expression of glucose transporter isoforms. Endocrinology 1990; 127:126-132.
28. Lilla V, Webb G, Rickenbach K et al. Differential gene expression in well-regulated and dysregulated pancreatic beta-cell (MIN6) sublines. Endocrinology 2003;144:1368-1379.
29. Jaques F, Jousset H, Tomas A et al. Dual effect of cell-cell contact disruption on cytosolic calcium and insulin secretion. Endocrinology 2008;149:2494-2505.
30. Ricordi C, Lacy PE, Finke EH et al. Automated method for isolation of human pancreatic islets. Diabetes 1988;37:413-420.
31. Vantyghem MC, Balavoine AS, Caiazzo R et al. Diabetes cell therapy: A decade later. Minerva Endocrinol 2011;36:23-39.
32. Movahedi B, Gysemans C, Jacobs-Tulleneers-Thevissen D et al. Pancreatic duct cells in human islet cell preparations are a source of angiogenic cytokines interleukin-8 and vascular endothelial growth factor. Diabetes 2008; 57:2128-2136.
33. Parnaud G, Bosco D, Berney T et al. Proliferation of sorted human and rat beta cells. Diabetologia 2008;51:91-100.
34. Nielsen JH. Beta-cell function in isolated human pancreatic islets in long-term tissue culture. Acta Biol Med Ger 1981;40:55-60.
35. Assady S, Maor G, Amit M et al. Insulin production by human embryonic stem cells. Diabetes 2001;50:1691-1697.
36. D'Amour KA, Bang AG, Eliazer S et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006;24:1392-1401.
37. Kroon E, Martinson LA, Kadoya K et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 2008;26:443-452.
38. Kelly OG, Chan MY, Martinson LA et al. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nat Biotechnol 2011;29:750-756.
39. Rezania A, Bruin JE, Riedel MJ et al. Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 2012;61:2016-2029.
40. Bar-Nur O, Russ HA, Efrat S et al. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 2011;9:17-23.
41. Maehr R, Chen S, Snitow M et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 2009;106:15768-15773.
42. Tateishi K, He J, Taranova O et al. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem 2008; 283:31601-31607.
43. Ferber S, Halkin A, Cohen H et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000;6:568-572.
44. Kahn A. Converting hepatocytes to betacells: A new approach for diabetes? Nat Med 2000;6:505-506.
45. Zalzman M, Anker-Kitai L, Efrat S. Differentiation of human liver-derived, insulin-producing cells toward the beta-cell phenotype. Diabetes 2005;54:2568-2575.
46. Sapir T, Shternhall K, Meivar-Levy I et al. Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells. Proc Natl Acad Sci USA 2005;102:7964-7969.
47. Zhou Q, Brown J, Kanarek A et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008;455:627-632.
48. Kulkarni RN, Mizrachi EB, Ocana AG et al. Human beta-cell proliferation and intracellular signaling: Driving in the dark without a road map. Diabetes 2012;61:2205-2213.
49. Rieck S, Zhang J, Li Z et al. Overexpression of hepatocyte nuclear factor-4alpha initiates cell cycle entry, but is not sufficient to promote beta-cell expansion in human islets. Mol Endocrinol 2012;26:1590-1602.
50. Gershengorn MC, Hardikar AA, Wei C et al. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 2004;306:2261-2264.
51. Russ HA, Bar Y, Ravassard P et al. In vitro proliferation of cells derived from adult human beta-cells revealed by cell-lineage tracing. Diabetes 2008;57:1575-1583.
52. Russ HA, Sintov E, Anker-Kitai L et al. Insulin-producing cells generated from dedifferentiated human pancreatic beta cells expanded in vitro. PLoS One 2011;6:e25566.
53. de la Tour D, Halvorsen T, Demeterco C et al. Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol Endocrinol 2001;15:476-483.
54. Ball AJ, Abrahamsson AE, Tyrberg B et al. HES6 reverses nuclear reprogramming of insulin-producing cells following cell fusion. Biochem Biophys Res Commun 2007;355:331-337.
55. Narushima M, Kobayashi N, Okitsu T et al. A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol 2005;23:1274-1282.
56. Hohmeier HE, Newgard CB. Islets for all? Nat Biotechnol 2005;23:1231-1232.
57. Jin J, Park J, Kim K et al. Detection of differential proteomes of human beta-cells during islet-like differentiation using iTRAQ labeling. J Proteome Res 2009;8:1393-1403.
58. Wang S, Beattie GM, Mally MI et al. Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. Cell Transplant 1997;6:59-67.
59. Wang S, Beattie GM, Mally MI et al. Analysis of a human fetal pancreatic islet cell line. Transplant Proc 1997;29:2219.
60. Castaing M, Duvillie B, Quemeneur E et al. Ex vivo analysis of acinar and endocrine cell development in the human embryonic pancreas. Dev Dyn 2005;234:339-345.
61. Castaing M, Peault B, Basmaciogullari A et al. Blood glucose normalization upon transplantation of human embryonic pancreas into beta-cell-deficient SCID mice. Diabetologia 2001;44:2066-2076.
62. Castaing M, Guerci A, Mallet J et al. Efficient restricted gene expression in beta cells by lentivirus-mediated gene transfer into pancreatic stem/progenitor cells. Diabetologia 2005; 48:709-719.
63. Scharfmann R, Xiao X, Heimberg H et al. Beta cells within single human islets originate from multiple progenitors. PLoS One 2008;3: e3559.
64. Ravassard P, Emilie B-N, Hazhouz Y et al. A new strategy to generate functional insulinproducing cell lines by somatic gene transfer into pancreatic progenitors. PLoS One 2009;4: e4731.
65. Korsgren O, Jansson L, Eizirik D et al. Functional and morphological differentiation of fetal porcine islet-like cell clusters after transplantation into nude mice. Diabetologia 1991;34:379-386.
66. Kühl C, Hornnes PJ, Jensen SL et al. Gastric inhibitory polypeptide and insulin: Response to intraduodenal and intravenous glucose infusions in fetal and neonatal pigs. Endocrinology 1980;107:1446-1450.
67. Lukowiak B, Vandewalle B, Riachy R et al. Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J Histochem Cytochem 2001;49: 519-528.
68. Fleischer N, Chen C, Surana M et al. Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes 1998;47: 1419-1425.
69. Wang W, Walker JR, Wang X et al. Identification of small-molecule inducers of pancreatic beta-cell expansion. Proc Natl Acad Sci USA 2009;106:1427-1432.
70. Klinger S, Poussin C, Debril MB et al. Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14. Diabetes 2008;57:584-593.
71. Keymeulen B, Gillard P, Mathieu C et al. Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci USA 2006;103: 17444-17449.
72. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-238.
73. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 2007;117:2553-2561.
74. Schulz TC, Young HY, Agulnick AD et al. A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS One 2012;7:e37004.
75. Attali M, Stetsyuk V, Basmaciogullari A et al. Control of beta-cell differentiation by the pancreatic mesenchyme. Diabetes 2007;56: 1248-1258.
76. Stanger BZ, Tanaka AJ, Melton DA. Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver. Nature 2007;445:886-891.
77. Rachdi L, Aiello V, Duvillie B et al. L-Leucine alters pancreatic beta-cell differentiation and function via the mTor signaling pathway. Diabetes 2012;61:409-417.
78. Nir T, Dor Y. How to make pancreatic beta cells: Prospects for cell therapy in diabetes. Curr Opin Biotechnol 2005;16:524-529.
79. Mathis D, Vence L, Benoist C. Beta-cell death during progression to diabetes. Nature 2001;414:792-798.
80. Brezar V, Carel JC, Boitard C et al. Beyond the hormone: Insulin as an autoimmune target in type 1 diabetes. Endocr Rev 2011;32:623-669.
81. O'Sullivan ES, Vegas A, Anderson DG et al. Islets transplanted in immunoisolation devices: A review of the progress and the challenges that remain. Endocr Rev 2011;32: 827-844.